Definition:Estimated completion statement
📊 Estimated completion statement is a financial statement prepared at or around the closing of an insurance M&A transaction that sets out the target company's estimated net asset value, working capital, cash, debt, and other agreed financial metrics as of the effective closing date. In insurance deals, this document carries particular weight because the valuation of an insurance company or MGA depends heavily on items that are inherently uncertain — chief among them loss reserves, unearned premium reserves, and deferred acquisition costs — making the estimated completion statement a starting point for what is usually a contested post-closing true-up process.
⚙️ Typically, the seller prepares the estimated completion statement in accordance with agreed accounting policies set out in the share purchase agreement, which may reference IFRS 17, US GAAP, or local statutory accounting principles depending on the jurisdiction and regulatory context. The buyer then has a review period — often sixty to ninety days — to examine the statement and raise objections. In insurance transactions, disputes frequently center on the adequacy of technical reserves: the seller may have booked reserves at a best estimate, while the buyer's actuarial team applies more conservative assumptions. If the parties cannot agree on adjustments, the disagreement is typically escalated to an independent accountant or expert determination process. The difference between the estimated figures and the finally agreed numbers drives a purchase price adjustment — either additional payment to the seller or a clawback from the escrow.
🎯 For both sides of the table, the estimated completion statement is the financial anchor of the post-closing settlement. A seller who produces a clean, well-supported statement with transparent actuarial backing reduces the scope for buyer objections and accelerates the release of escrowed funds. A buyer who scrutinizes the statement carefully — especially the treatment of IBNR, reinsurance recoverables, and premium receivables — can identify material adjustments that protect against overpayment. In cross-border deals where the target operates across multiple regulatory regimes, such as an insurer with entities in both Solvency II jurisdictions and the U.S. state-based system, the preparation of the estimated completion statement can be especially complex due to differing reserving and capital recognition standards.
Related concepts: